Terumo Corp (4543.T)
4543.T on Tokyo Stock Exchange
5,030JPY
8:46pm EDT
5,030JPY
8:46pm EDT
Price Change (% chg)
¥-70 (-1.37%)
¥-70 (-1.37%)
Prev Close
¥5,010
¥5,010
Open
¥5,160
¥5,160
Day's High
¥5,160
¥5,160
Day's Low
¥4,985
¥4,985
Volume
233,900
233,900
Avg. Vol
1,061,711
1,061,711
52-wk High
¥5,830
¥5,830
52-wk Low
¥3,085
¥3,085
About
TERUMO CORPORATION operates in four business segment. The Hospital Products segment offers hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture,... (more)
Overall
| Beta: | 1.02 |
| Market Cap (Mil.): | ¥942,755.50 |
| Shares Outstanding (Mil.): | 189.88 |
| Dividend: | 29.00 |
| Yield (%): | 0.89 |
Financials
| 4543.T | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 20.05 | 27.50 | 37.76 |
| EPS (TTM): | 247.60 | -- | -- |
| ROI: | 7.92 | 9.26 | 18.76 |
| ROE: | 11.90 | 12.54 | 19.59 |
Heart stent with new polymer matches Abbott top seller in study
- A drug-coated heart stent from Japan's Terumo Corp with a dissolving polymer proved just as effective as Abbott Laboratories' top-selling Xience stent at preventing a second procedure to clear the artery, a large study found.
Heart stent with new polymer matches Abbott top seller in study
March 10 - A drug-coated heart stent from Japan's Terumo Corp with a dissolving polymer proved just as effective as Abbott Laboratories' top-selling Xience stent at preventing a second procedure to clear the artery, a large study found.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

